Subscribe

Stay Informed. Stay Ahead.

Subscribe to receive curated updates, expert insights, and practical education—delivered straight to your inbox.

Get timely coverage on new approvals, case-based discussions, conference highlights, and practical tools for everyday practice in community oncology and hematology.

Subscribe
*
Skip to main content
OncUpdates
  • Conferences
    • ASCO
      • Rapid Reactions
    • ASCO GU
    • ASCO GI
    • ASH
    • SABCS
    • ESMO
    • WCLC
  • Videos & Podcasts
    • Challenging Cases
      • Breast Cancer
      • GU Oncology
      • Hematology
      • Lung Cancer
    • New Approvals
      • Breast Cancer
      • GI Oncology
      • GU Oncology
      • Hematology
      • Lung Cancer
    • Tox Check
      • Breast Cancer
      • GI Oncology
      • GU Oncology
      • Hematology
      • Lung Cancer
    • Treatment Algorithms
      • Breast Cancer
      • Dermatology
      • GI Oncology
      • GU Oncology
      • Head and Neck Cancers
      • Hematology
      • Lung Cancer
      • Ovarian Cancer
  • Clinical Insights
    • Head & Neck Cancer
    • GU Oncology
      • Bladder Cancer
      • RCC
    • GI Oncology
      • Gastric/GEJ Cancer
      • Pancreatic Cancer
    • Breast Cancer
      • Early HR+
      • Metastatic HR+
    • Hematology
      • Polycythemia Vera
      • Multiple Myeloma
    • Lung Cancer
      • SCLC
      • NSCLC
  • Resource Centers
    • Cell Therapy
    • Pancreatic Cancer
    • Metastatic Breast Cancer
  • Articles
    • GI Oncology
    • GU Oncology
    • Hematology
    • Lung Cancer
  • Events
  • Conferences
    • ASCO
      • Rapid Reactions
    • ASCO GU
    • ASCO GI
    • ASH
    • SABCS
    • ESMO
    • WCLC
  • Videos & Podcasts
    • Challenging Cases
      • Breast Cancer
      • GU Oncology
      • Hematology
      • Lung Cancer
    • New Approvals
      • Breast Cancer
      • GI Oncology
      • GU Oncology
      • Hematology
      • Lung Cancer
    • Tox Check
      • Breast Cancer
      • GI Oncology
      • GU Oncology
      • Hematology
      • Lung Cancer
    • Treatment Algorithms
      • Breast Cancer
      • Dermatology
      • GI Oncology
      • GU Oncology
      • Head and Neck Cancers
      • Hematology
      • Lung Cancer
      • Ovarian Cancer
  • Clinical Insights
    • Head & Neck Cancer
    • GU Oncology
      • Bladder Cancer
      • RCC
    • GI Oncology
      • Gastric/GEJ Cancer
      • Pancreatic Cancer
    • Breast Cancer
      • Early HR+
      • Metastatic HR+
    • Hematology
      • Polycythemia Vera
      • Multiple Myeloma
    • Lung Cancer
      • SCLC
      • NSCLC
  • Resource Centers
    • Cell Therapy
    • Pancreatic Cancer
    • Metastatic Breast Cancer
  • Articles
    • GI Oncology
    • GU Oncology
    • Hematology
    • Lung Cancer
  • Events

Explore Videos, Articles & More

GU Oncology

Curated articles in GU oncology highlighting emerging data, biomarker-driven strategies, and evolving treatment approaches across genitourinary cancers to support evidence-based clinical decision-making.

Home / Articles / GU Oncology
Refining the Post-IO Strategy in mRCC: The Role of TKIs and the Nuance of Timing
Refining the Post-IO Strategy in mRCC: The Role of TKIs and the Nuance of Timing

Karan Jatwani, MD, Urvi Patel, DO, MPH

The Evolving Landscape of Refractory Renal Cell Carcinoma 
The Evolving Landscape of Refractory Renal Cell Carcinoma 

Michael Serzan, MD

TKIs After Upfront Immunotherapy in Metastatic RCC: A Practical Review
TKIs After Upfront Immunotherapy in Metastatic RCC: A Practical Review

Brendan Guercio, MD

OncUpdates

Empowering oncology professionals with The latest insights, breakthroughs, And expert opinions

Quick Links

  • About Us
  • Upcoming Events
  • Follow on X
  • Follow on LinkedIn
  • Follow on YouTube

Legal

  • Terms of Use
  • Privacy Policy
  • Cookie Settings
  • Authors
  • Contact Us

Subscribe to Our Newsletters


Property of SignifyMD LLC, All Rights Reserved 2026 SignifyMD LLC PO Box 512, Brielle, NJ 08730


Oncology Resources | Hematology Support | Community Oncology